title: The ECASS III results and the tPA paradox.
authors.forename: Stephen
authors.initials: S
authors.lastname: Davis
authors.forename: Geoffrey
authors.initials: G
authors.lastname: Donnan
mesh_terms: D002986:Clinical Trials as Topic; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006801:Humans; D020521:Stroke / Q000188:drug therapy*; D013995:Time; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage*
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator